Literature DB >> 35305331

Epstein-Barr virus and multiple sclerosis: supporting causality.

Francesca Aloisi1, Marco Salvetti2.   

Abstract

Entities:  

Mesh:

Year:  2022        PMID: 35305331     DOI: 10.1016/S1474-4422(22)00086-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  2 in total

1.  Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID.

Authors:  Michael J Peluso; Tyler-Marie Deveau; Sadie E Munter; Dylan Ryder; Amanda Buck; Gabriele Beck-Engeser; Fay Chan; Scott Lu; Sarah A Goldberg; Rebecca Hoh; Viva Tai; Leonel Torres; Nikita S Iyer; Monika Deswal; Lynn H Ngo; Melissa Buitrago; Antonio Rodriguez; Jessica Y Chen; Brandon C Yee; Ahmed Chenna; John W Winslow; Christos J Petropoulos; Amelia N Deitchman; Joanna Hellmuth; Matthew A Spinelli; Matthew S Durstenfeld; Priscilla Y Hsue; J Daniel Kelly; Jeffrey N Martin; Steven G Deeks; Peter W Hunt; Timothy J Henrich
Journal:  medRxiv       Date:  2022-07-22

2.  Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis.

Authors:  Tilman Schneider-Hohendorf; Lisa Ann Gerdes; Béatrice Pignolet; Roland Liblau; Heinz Wiendl; Nicholas Schwab; Rachel Gittelman; Patrick Ostkamp; Florian Rubelt; Catarina Raposo; Björn Tackenberg; Marianne Riepenhausen; Claudia Janoschka; Christian Wünsch; Florence Bucciarelli; Andrea Flierl-Hecht; Eduardo Beltrán; Tania Kümpfel; Katja Anslinger; Catharina C Gross; Heidi Chapman; Ian Kaplan; David Brassat; Hartmut Wekerle; Martin Kerschensteiner; Luisa Klotz; Jan D Lünemann; Reinhard Hohlfeld
Journal:  J Exp Med       Date:  2022-09-01       Impact factor: 17.579

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.